ASTH
Astrana Health Inc
NASDAQ: ASTH · HEALTHCARE · MEDICAL CARE FACILITIES
$36.67
-0.73% today
Updated 2026-10-28
Market cap
$1.83B
P/E ratio
44.35
P/S ratio
0.48x
EPS (TTM)
$0.83
Dividend yield
—
52W range
$18 – $52
Volume
0.4M
Astrana Health Inc (ASTH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$36.67
12-Month target
$11.04
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.8B | $1.1B | $1.4B | $2.0B | $3.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 1.06%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.